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The monoterpene d-limonene exhibits chemotherapeutic and chemopreventive potential in breast cancer patients. D-limonene and
its related compounds, perillyl alcohol and perillyl aldehyde, were chosen as candidate drugs for application in a screen for nontoxic
inhibitors of cell migration. Using the nontumorigenic human breast cell line MCF-10A, we delineated the toxicity as greatest for
the perillyl aldehyde, intermediate for perillyl alcohol, and least for limonene. A noncytotoxic concentration of 0.5mmol/L perillyl
alcohol inhibited the migration, while the same concentration of limonene failed to do so. Adhesion of the MCF-10A cell line and
the human breast cancer cell line MDA-MB 435 to ﬁbronectin was unaﬀected by 1.5mmol/L perillyl alcohol. 0.4mmol/L perillyl
alcohol inhibited the growth of MDA-MB 435 cells. All migration-inhibiting concentrations of perillyl alcohol for MDA-MB 435
cells proved to be toxic. These results suggest that subtoxic doses of perillyl alcohol may have prophylactic potential in the treatment
of breast cancer.
INTRODUCTION
Cancer remains the second leading cause of death in the
US,AmericanCancerSociety,http://www.cancer.org.T umor
metastasis is the most deadly characteristic of cancer. Unlike
primary tumors that can be surgically removed and treated
with adjuvant chemotherapy and/or radiotherapy, metas-
tases are diﬃcult to treat and usually prove fatal [1].
The development of secondary tumors is a sequential
process, commonly referred to as a “metastatic cascade,” and
failuretocompleteanyonesteppreventsmetastasis[1].Dur-
ing the metastatic cascade, primary tumor cells digest their
surrounding extracellular matrix, migrate through intersti-
tial spaces, and enter blood or lymphatic vessels where they
are carried to distant organs. Once lodged in the target or-
gans, these cells migrate into the interstitial spaces and con-
tinue to grow to develop a secondary tumor, or metastasis
[2].Thus,themigrationandinvasionofcancercellsprovides
many potential targets for therapeutic intervention.
Most anticancer drugs target the hyperproliferation of
metastatic cells. While many of these drugs are eﬃcacious
in treating the beginning stages of cancer, none are curative
formetastatic disease. Any delay in the diagnosis alsorenders
many of these drugs ineﬀective [3]. In addition, antiprolifer-
ation compounds cause many adverse side eﬀects, including
nausea, vomiting, suppressed immune system, and hair loss.
It is, therefore, paramount that alternative therapies be de-
veloped to treat a greater scope of the disease with less dis-
turbance to the wellbeing of the patient.
Even though tumor cell migration is a hallmark feature
of metastasis, since 1978, fewer than 100 compounds that
havesomecapacitytoinhibittumorcellmigrationhavebeen
reported; however, thousands of compounds have yet to be
tested. To address the need for a more comprehensive screen
of possible antimigration compounds, we recently, devel-
opedanautomatedhigh-throughputcytotoxicity/cellmigra-
tion assay suitable for screening large numbers of samples
[4].
During the development of our automated assay, we ap-
plied cell proliferation and migration assays to screen drugs,
already known to have anticancer eﬀects, for noncytotoxic
antimigration properties. This report focuses on the eﬀects
ofd-limoneneanditsderivatives.Thechemotherapeuticand
chemopreventative eﬀects of d-limonene, a monoterpene
found in the essential oils of citrus fruits, spices, and herbs,
have been studied extensively in spontaneous and chemi-
cally induced rodent tumors [5]. Limonene serves as a pre-
cursor to other oxygenated monocyclic monoterpenes such
as carveol, carvone, menthol, perillyl alcohol (POH), and
perillyl aldehyde [6]. Due to success in tumor regression in
various rodent cancer models, clinical testing of the cancer
chemotherapeuticactivityofthesecompoundsisinprogress,
including Phase I clinical trials of POH in breast cancer pa-
tients [7, 8].
D-limonene and its derivatives disrupt isoprenylation of
members of the Ras family of G proteins by geranylgeranyl
transferases in some instances [9], though the eﬀects of this
disruption on downstream cellular behaviors are only now
being elucidated. Thus much of the focus far has been on
the inhibition of the cell cycle machinery and the induction
of apoptosis [10]. The eﬀects of these compounds on migra-
tion, especially in breast cells, are unreported to date.2:3 (2002) Perillyl Alcohol Inhibits Breast Cell Migration 137
We report here that POH inhibits migration of both ma-
lignant and nonmalignant human breast cells, and that mi-
gration inhibiting doses also prove cytotoxic in malignant
cells. These results suggest that subtoxic doses of POH may
act as a preventative treatment for breast cancer.
MATERIALS AND METHODS
Materials
MCF-10A and MDA-MB 435 cells were purchased from
American Type Culture Collection. Fibronectin, epidermal
growth factor, cholera toxin, and insulin were obtained from
Calbiochem (La Jolla, Calif). Hydrocortisone was purchased
fromSigma-AldrichChemicals(St.Louis,Mo).Horseserum
was purchased from Irvine Scientiﬁc (Santa Ana, Calif).
Calcein-AM was purchased from Molecular Probes (Eugene,
Ore).TranswellmigrationplateswerepurchasedfromCostar
(Cambridge, Mass). Cell culture ﬂasks and 96-well plates
were purchased from VWR (Plainﬁeld, NJ). Limonene,
POH, and perillyl aldehyde were purchased from Aldrich
Chemical Co. (Milwaukee, Wis).
Cellculture
Cells were grown in 75cm2 Falcon tissue culture ﬂasks
obtained from VWR (Plainﬁeld, NJ). Cells were main-
tained at 37◦C and 5% CO2 in humidiﬁed chambers.
MCF-10A cells were maintained in AM media—1:1 mix-
ture of Ham’s F-12 medium and Dulbecco’s Modiﬁed Ea-
gle’s Medium High Glucose with 2mmol/L L-glutamine
from Irvine Scientiﬁc (Santa Ana, Calif, USA) supplemented
with the following: epidermal growth factor (20ng/mL),
cholera toxin (100ng/mL), insulin (0.01mg/mL), hydrocor-
tisone(500ng/mL),and5%horseserum.MDA-MB435cells
were maintained in RPMI Medium 1640 supplemented with
10% fetal bovine serum and 1% L-glutamine (29.2mg/mL),
penicillin G (10000units/mL) and streptomycin sulfate
(10000µg/mL) from Irvine Scientiﬁc (Santa Ana, Calif).
Cells were routinely passaged using trypsin/EDTA from
Irvine Scientiﬁc (Santa Ana, Calif).
Proliferationassay
In 96-well plates, 30 × 103 cells were seeded in the
appropriate serum-containing media and incubated for 2
hours at 37◦C and 5% CO2 in humidiﬁed chambers. Cells
were then washed twice with PBS and grown in migra-
tion media (MCF-10A: DMEM and 0.1% BSA; MDA-MB
435: RPMI 1640 and 0.1% BSA) with indicated concentra-
tions of limonene, perillyl alcohol, or perillyl aldehyde for
24hours. Cells were then washed twice with PBS, ﬁxed in
3.7% formaldehyde for 15minutes, stained with crystal vi-
olet and lysed with 1% sodium docecyl sulfate (SDS). Ab-
sorbancewasreadat595nmusingaplatereader.Growthwas
measured as compared to a standard curve of cells grown in
serum-containing media.
Adhesionassay
Cell adhesion assays were performed as previously de-
scribed in Costar 96-well Cell Culture Cluster plates [11].
Tissue culture plates were coated with puriﬁed ﬁbronectin
(20µg/mL in 50mmol/L carbonate buﬀer, pH 9.3) for 1
hour at room temperature. Wells were then washed with
phosphate-buﬀered saline with 0.2% Tween-20 (PBST),
blockedwith5%blotto(PBSTwith5%skimmilk)for1hour
at 25◦C. Wells were then washed twice with PBST prior to
assay. Cells were seeded at a concentration of 1.0 × 106 per
well in cell culture plates with and without migration me-
dia(MCF-10A:DMEMand0.1%BSA;MDA-MB435:RPMI
1640 and 0.1% BSA) and perillyl alcohol and were allowed
to attach for 30minutes at 37◦C in a humidiﬁed incubator
containing5%CO2.Unboundcellsweredislodgedbyinvert-
ing, submerging and rocking the plate in PBS for 15minutes.
Cells were then ﬁxed in 3.7% formaldehyde, stained with
crystal violet, and lysed with 1% SDS. Absorbance was mea-
sured at 595nm in a plate reader.
Migrationassay
Cell migration assays were performed as previously de-
scribed in Costar transwell ﬁlter plates [6]. Filters were
coated with puriﬁed ﬁbronectin at a concentration of
20µg/mLincarbonatebuﬀer(50mmol/L,pH9.3)for1hour
atroomtemperature.Filterswerethenaspiratedandblocked
in blotto (phosphate-buﬀered saline with 0.2% Tween-20
( P B S T )a n d5 %s k i mm i l k )f o r1h o u ra tr o o mt e m p e r a -
ture. Next, ﬁlters were washed in PBST prior to the assay.
Thirty minutes prior to starting the assay, cells were pre-
incubatedat37◦Cinmigrationmediaandtheindicatedcon-
centrations of POH. Cells were seeded at a concentration
of 1.2 × 106/well on transwell ﬁlters with and without ﬁ-
bronectin in the presence or absence of soluble growth fac-
tors (serum-enriched media) and varying concentrations of
POHandallowedtomigratefor18hoursat37◦Cin5%CO 2.
Thirty minutes before measuring the migration, 5µmol/L of
calcein-AM (Molecular Probes; Eugene, Ore) was added to
the migration wells. To quantify the migration, cells were re-
moved from the top of the ﬁlter with cotton swabs, washed
in phosphate-buﬀered saline and the ﬂuorescence measured
fromthebottomoftheﬁlterwithaplatereaderfortheincor-
poration of calcein-AM [7]. Relative ﬂuorescence values for
each experimental condition were expressed relative to con-
trol untreated samples.
RESULTS AND DISCUSSION
D-limonene and its derivatives, POH and perillyl alde-
hyde, exhibited diﬀerent degrees of toxicity in a 24-hour
growth assay. D-limonene did not inhibit growth of MCF-
10A cells at concentrations up to 1.0mmol/L (Figure 1)o r
greater (not shown), while 0.5mmol/L perillyl aldehyde was
completely toxic. In contrast, 0.5mmol/L POH was not cy-
totoxic, but concentrations of 0.75mmol/L and 1.0mmol/L
werecytostaticandcytotoxic,respectively.Therelativelyhigh
toxicity of perillyl aldehyde may be due to a proportionally
high aﬃnity for the enzymes farnesyl transferase (FT) and
geranylgeranyl transferase (GGT) as has been shown for per-
illic acid methyl ester, a minor metabolite of limonene, and
POH [12]. These enzymes are involved in post-translational138 Johanna E. Wagner et al 2:3 (2002)
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Figure 1. Monoterpenes exhibit varying degrees of inhibition of breast cell
growth. MCF-10A cells were plated at 30 × 103 cells/well (dashed line) in
serum-free minimal medium containing the indicated concentrations of
monoterpenes, and counted 24 hours later. Bars represent mean ± stan-
dard deviation (n = 10). A student-Numan-Keuls test identiﬁed ﬁve groups
(letters A–E; P ≤ .05) which were statistically diﬀerent from one another
(ANOVA F:[9, 98] = 121.63, P<. 0001).
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Figure 2. Perillyl alcohol, but not d-limonene, inhibits breast cell migra-
tion. MCF-10A cells were allowed to migrate towards the bottom side of an
8-µm pore ﬁlter coated with ﬁbronectin for 18 hours in serum-free mini-
mal medium containing the indicated concentrations of monoterpenes, or
serum as a control. Migration towards nonfat dried milk (blotto) served as
a negative control for random migration. Migration was quantitated by ﬂu-
orescently labeling cells on the bottom of the ﬁlters and reading the ﬂuores-
cencewithaplatereader.ResultsexpressedasmeanofRelativeFluorescence
Units, ± standard deviation (n = 3). A student-Numan-Keuls test identiﬁed
ﬁve groups (letters A–E; P ≤ .05) which were statistically diﬀerent from one
another (ANOVA F:[7, 23] = 231.76, P<. 0001).
modiﬁcation of small G-proteins that are involved in a
myriad of cell activities such as growth and migration. In-
hibition of FT and GGT is suspected to be the basis of the
antitumor eﬀects of POH and limonene [12]. However, in
accord with our data, an equal concentration of limonene is
0
0.5
1
1.5
2
2.5
A
b
s
o
r
b
a
n
c
e
(
5
9
5
n
m
)
D
AB AB
A
AB B
C
Plastic 0 0.5 1.0 1.5 2.0 2.5
(mmol/L)
[Perillyl alcohol]
(a)
0
0.5
1
1.5
2
2.5
A
b
s
o
r
b
a
n
c
e
(
5
9
5
n
m
)
D
A A AA
B
C
Plastic 0 0.5 1.0 1.5 2.0 2.5
(mmol/L)
[Perillyl alcohol]
(b)
Figure 3. Perillyl alcohol (≤ 1.5mmol/L) does not interfere with breast cell
adhesion to ﬁbronectin. MCF-10A cells (a) or MDA-MB-435 cells (b) were
plated on ﬁbronectin for 30minutes in the presence of the indicated con-
centrations of perillyl alcohol. Adherent cells were quantitated by staining
with crystal violet, solubilizing adherent dye, and measuring absorbance at
595nm. Results expressed as mean ± standard deviation (n = 8). A student-
Numan-Keuls test identiﬁed in (a) two partly overlapping groups (letters A
andB)andtwoindependent groups(letters CandD);andin (b),fourinde-
pendent groups (letters A–D), P ≤ .05. All groups are statistically diﬀerent
from one another (panel (a), ANOVA F:[6,55] = 144.88, P<. 0001; panel
(b), ANOVA F:[6, 41] = 252.45, P<. 0001).
not as eﬀective as POH in blocking cell proliferation in other
cell types [12, 13].
Migration assays established that, a subtoxic dose
(0.5mmol/L) of POH inhibited haptotactic migration of
M C F - 1 0 Ac e l l so nﬁ b r o n e c t i n( Figure 2). Again, this diﬀer-
ence is most likely attributable to POH, having a greater po-
tency than limonene in the inhibition of small G-protein iso-
prenylation [13]. A probable mediator of this inhibited mi-
gration is the small G-protein RhoA, a member of the Rho
family of small GTPases, that is involved in signaling a path-
way for cell migration [13, 14].
To test the eﬀect of POH on adhesion to ﬁbronectin,
both noncancerous (MCF-10A) cells and cancerous (MDA-
MB 435) cells were exposed for 18 hours to increasing con-
centrations of POH prior to a 30-minute adhesion assay.
Both MCF-10A and MDA-MB 435 cell lines tolerated up to
1.5mmol/L POH with no statistically signiﬁcant variation2:3 (2002) Perillyl Alcohol Inhibits Breast Cell Migration 139
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Figure 4. 0.5mmol/L perillyl alcohol is a noncytotoxic inhibitor of MCF-
10A cell migration on ﬁbronectin. Parallel measurements of cell migration
(panel (a)) and cell growth (panel (b)) were performed as described for Fig-
ures 1 and 2 using MCF-10A cells exposed to the indicated concentrations
of perillyl alcohol in a serum-free minimal medium. For panel A, a student-
Numan-Keuls test identiﬁed four groups, two of which overlapped (letters
A–D; P ≤ .05). For panel (b), a student-Numan-Keuls test identiﬁed six
groups (letters A–F; P ≤ .05). All groups in each panel were statistically dif-
ferent from one another (panel (a), ANOVA F:[6, 20] = 33.80, P<. 0001;
panel (b), ANOVA F:[7, 79] = 253.58, P<. 0001).
compared to 0mmol/L (Figure 3) .T h et r e a t e dc e l l se x h i b -
ited rounding and a loss of cytoskeletal organization, but
remained viable as determined by Trypan Blue exclusion
and MTT reduction assays (Wagner et al, unpublished data,
2000). These results, independently, conﬁrm the low toxicity
of POH, and suggest that POH may inhibit the migration by
disrupting the cytoskeletal machinery required to exert the
necessary force for lamellar extension. Integrin mediated ad-
hesion, however, remained unaﬀected.
To, directly, assess the dose response to POH treatment,
growth and migration assays were performed in parallel for
both cell lines. In MCF-10A cells, 0.5mmol/L POH inhib-
ited the migration by over 75% and allowed the cell growth,
although at a lower rate (Figure 4). In contrast, in MDA-
MB 435 cells, this dose inhibited the migration by over 85%
but also reduced the cell number by nearly 20%. In fact, all
concentrations of POH that inhibited migration were cyto-
toxic in this cell line (Figure 5). This may be because this cell
line expressing a higher level of RhoA, as has been reported
in other tumor cells as compared to nontumorigenic cells
[15]. An increased invasive phenotype is also characteristic
0
11 0 4
21 0 4
31 0 4
41 0 4
51 0 4
61 0 4
R
F
U
A
B
B
B
C
D D
serum 0 0.1 0.2 0.4 0.5 blotto
(mmol/L)
[Perillyl alcohol]
(a)
0
10
20
30
40
50
60
70
C
e
l
l
#
×
1
0
3
A
B
C C
CC
D
E
0 0.2 0.4 0.5 0.6 0.7 0.8 1.0
(mmol/L)
[Perillyl alcohol]
(b)
Figure 5. Perillyl alcohol is a cytotoxic inhibitor of MDA-MB-435 cell mi-
gration on ﬁbronectin. Parallel measurements of cell migration (panel (a))
and cell growth (panel (b)) were performed as described for Figures 1 and 2
usingMDA-MB-435cellsexposedtotheindicatedconcentrationsofperillyl
alcohol in serum-free minimal medium. For panel (a), a student-Numan-
Keuls test identiﬁed four groups (letters A–D; P ≤ .05). For panel (b), a
student-Numan-Keuls test identiﬁed ﬁve groups (letters A–E; P ≤ .05). All
groups in eachpanel were statisticallydiﬀerent from one another (panel (a),
ANOVA F:[6, 23] = 33.80, P<. 0001; panel (b), ANOVA F:[7, 80] = 56.08,
P<. 0001).
of some liver and breast tumor cells in response to RhoA ac-
tivation [15, 16]. Additionally, POH treatment signiﬁcantly
increases apoptosis in pancreatic cancer cells relative to non-
malignant pancreas cells [17]. Thus, POH may exert its ef-
fects through separate mechanisms in MCF-10 and MDA-
MB 435 cells.
Given that a noncytotoxic dose of POH can inhibit the
migration of noncancerous breast cells, and the same dose
can kill cancerous breast cells, this suggests the possibility
that POH may be used as a prophylactic treatment for pa-
tients at risk of developing breast cancer. Such a strategy is
currently being used with the anti-estrogen drug, tamoxifen
[18] .F u r t h e rs t u d i e sa r eu n d e rw a yi no u rl a b o r a t o r yt oe x -
plore the eﬀects of low doses of POH on tumor progression.
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